Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A novel preventive therapy for paclitaxel-induced cognitive deficits: preclinical evidence from C57BL/6 mice
Petra Huehnchen, Wolfgang Boehmerle, Andreas Springer, et al.
Translational Psychiatry (2017) Vol. 7, Iss. 8, pp. e1185-e1185
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management
Ben Fleming, Paul Edison, Laura Kenny
BMJ (2023), pp. e071726-e071726
Closed Access | Times Cited: 42
Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases
Lien D. Nguyen, Barbara E. Ehrlich
EMBO Molecular Medicine (2020) Vol. 12, Iss. 6
Open Access | Times Cited: 125
GDF-15 Neutralization Alleviates Platinum-Based Chemotherapy-Induced Emesis, Anorexia, and Weight Loss in Mice and Nonhuman Primates
Danna M. Breen, Hanna Kim, Donald Bennett, et al.
Cell Metabolism (2020) Vol. 32, Iss. 6, pp. 938-950.e6
Open Access | Times Cited: 122
Chemotherapy-induced neuroinflammation is associated with disrupted colonic and bacterial homeostasis in female mice
Brett R. Loman, K.R. Jordan, Bronson A. Haynes, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 106
Chemotherapy-induced cognitive impairment (CICI): An overview of etiology and pathogenesis
Noha M. Mounier, Amany E. Abdel-Maged, Sara A. Wahdan, et al.
Life Sciences (2020) Vol. 258, pp. 118071-118071
Closed Access | Times Cited: 101
Taxane‐induced neurotoxicity: Pathophysiology and therapeutic perspectives
Robson da Costa, Giselle F. Passos, Nara Lins Meira Quintão, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 14, pp. 3127-3146
Open Access | Times Cited: 96
Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy
Petra Huehnchen, Christian Schinke, Nikola Bangemann, et al.
JCI Insight (2022) Vol. 7, Iss. 6
Open Access | Times Cited: 65
Mechanistic insights into chemotherapy-induced circadian disruption using rodent models
Zoe M. Tapp, Abhijit Ghosh, Karl Obrietan, et al.
Trends in Neurosciences (2025)
Closed Access | Times Cited: 1
Cisplatin and methotrexate induce brain microvascular endothelial and microglial senescence in mouse models of chemotherapy-associated cognitive impairment
Boglarka Csik, Kiana Vali Kordestan, Rafał Gulej, et al.
GeroScience (2025)
Open Access | Times Cited: 1
Chemotherapy-Induced Cognitive Impairment and Hippocampal Neurogenesis: A Review of Physiological Mechanisms and Interventions
Melanie J. Sekeres, Meenakshie Bradley-Garcia, Alonso Martínez-Canabal, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12697-12697
Open Access | Times Cited: 50
Modeling chemotherapy induced neurotoxicity with human induced pluripotent stem cell (iPSC) -derived sensory neurons
Christian Schinke, Valeria Fernández Vallone, Andranik Ivanov, et al.
Neurobiology of Disease (2021) Vol. 155, pp. 105391-105391
Open Access | Times Cited: 42
Oral sodium butyrate supplementation ameliorates paclitaxel-induced behavioral and intestinal dysfunction
Claudia Cristiano, Mariarosaria Cuozzo, Lorena Coretti, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113528-113528
Closed Access | Times Cited: 32
Cognitive impairment after cytotoxic chemotherapy
Petra Huehnchen, Antonia van Kampen, Wolfgang Boehmerle, et al.
Neuro-Oncology Practice (2019) Vol. 7, Iss. 1, pp. 11-21
Open Access | Times Cited: 48
Animal models of chemotherapy-induced cognitive decline in preclinical drug development
Jeena John, Manas Kinra, Jayesh Mudgal, et al.
Psychopharmacology (2021) Vol. 238, Iss. 11, pp. 3025-3053
Open Access | Times Cited: 37
Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions
Giovana R. Onzi, Nathalia D’Agustini, Solange Cristina García, et al.
Drug Safety (2022) Vol. 45, Iss. 6, pp. 601-621
Closed Access | Times Cited: 23
Microtubule-modulating drugs alter sensitivity to isoflurane in mice
Na Li, Zerong You, Yang Ren, et al.
BMC Anesthesiology (2025) Vol. 25, Iss. 1
Open Access
An update on neurobiological mechanisms involved in the development of chemotherapy-induced cognitive impairment (CICI)
Laura Catalina Murillo, Jhon Jairo Sutachan, Sonia Luz Albarracín
Toxicology Reports (2023) Vol. 10, pp. 544-553
Open Access | Times Cited: 12
Characterisation of the effects of the chemotherapeutic agent paclitaxel on neuropathic pain-related behaviour, anxiodepressive behaviour, cognition, and the endocannabinoid system in male and female rats
Cinzia Di Marino, Alvaro Llorente‐Berzal, Alba M. Diego, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Results of the preclinical multicenter randomized controlled paclitaxel-induced neuropathy prevention replication study (PINPRICS)
Wolfgang Boehmerle, Tim Hagenacker, Markus Leo, et al.
BMC Research Notes (2025) Vol. 18, Iss. 1
Open Access
TRPV4 inhibition prevents paclitaxel-induced neurotoxicity in preclinical models
Wolfgang Boehmerle, Petra Huehnchen, Sabrina Lin Lin Lee, et al.
Experimental Neurology (2018) Vol. 306, pp. 64-75
Closed Access | Times Cited: 34
Autophagy lipidation machinery regulates axonal microtubule dynamics but is dispensable for survival of mammalian neurons
Albert Negrete‐Hurtado, Melina Overhoff, Sujoy Bera, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 30
Pharmacological rescue of cognitive function in a mouse model of chemobrain
Lien D. Nguyen, Tom T. Fischer, Barbara E. Ehrlich
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 26
Neuroimmune Consequences of eIF4E Phosphorylation on Chemotherapy-Induced Peripheral Neuropathy
Nilesh M. Agalave, Prapti H. Mody, Thomas A. Szabo-Pardi, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 24
Paclitaxel Regulates TRPA1 Function and Expression Through PKA and PKC
Julio C. Sánchez, Laura V. Muñoz, María-Leonor Galindo-Márquez, et al.
Neurochemical Research (2022) Vol. 48, Iss. 1, pp. 295-304
Open Access | Times Cited: 16
Microglia are implicated in the development of paclitaxel chemotherapy-associated cognitive impairment in female mice
Corena V. Grant, Kyle A. Sullivan, Kylie M. Wentworth, et al.
Brain Behavior and Immunity (2022) Vol. 108, pp. 221-232
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top